The product has not yet been released on the market.
Description
Tadalafil-Tchaikapharma contains the active substance tadalafil, which belongs to a group of medicines known as phosphodiesterase type 5 inhibitors. Tadalafil improves blood flow by relaxing the smooth muscle of blood vessels. This results in improved erectile function and relief of urinary symptoms associated with benign prostatic hyperplasia. Tadalafil Tchaikapharma is not intended for use in women.
Indications
Tadalafil-Tchaikapharma is indicated in adult men for:
- treatment of erectile dysfunction, characterized by the inability to achieve or maintain an erection sufficient for sexual activity;
- treatment of urinary symptoms associated with benign prostatic hyperplasia, such as difficulty in urination, sensation of incomplete bladder emptying and increased frequency of urination, including during the night.
Subject to medical prescription.
Concentration and pharmaceutical form: 5 mg; 10 mg; 20 mg film-coated tablets